Abstract
In the current study, we developed a HPLC method to quantitatively measure the permeability of the BpT-based chelators, 2-benzoylpyridine 4-ethyl-3-thiosemicarbazone (Bp4eT) and 2-benzoylpyridine 4-allyl-3-thiosemicarbazone (Bp4aT), across human colorectal adenocarcinoma (Caco-2) monolayers as a model of gut absorption. In aqueous solution, Bp4eT and Bp4aT formed inter-convertible Z and E isomers that were resolved by HPLC. Peak area was linear with respect to chelator concentration. Acceptable within-day and between-day precision (
| Original language | English |
|---|---|
| Pages (from-to) | 25-32 |
| Number of pages | 8 |
| Journal | Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences |
| Volume | 906 |
| DOIs | |
| Publication status | Published - 1 Oct 2012 |
| Externally published | Yes |
Keywords
- HIV-1 iron chelator
- HPLC method development
- Inter-convertible Z and E isomers
- Caco2 drug permeability
- INHIBIT HIV-1 TRANSCRIPTION
- IRON CHELATORS
- GENE-EXPRESSION
- CELLS
- TRANSPORT
- DESFERRIOXAMINE
- MECHANISMS
- SERIES
- IDENTIFICATION
- DEFERIPRONE
Fingerprint
Dive into the research topics of 'Development of a sensitive HPLC method to measure in vitro permeability of E- and Z-isomeric forms of thiosemicarbazones in Caco-2 monolayers'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver